feed,title,long_url,short_url
Benzinga,Arbutus Biopharma Q1 Exceeds Consensus View; Cuts Cash Burn Guidance,https://benzinga.com/news/earnings/23/05/32218028/arbutus-biopharma-q1-exceeds-consensus-view-cuts-cash-burn-guidance,https://da.gd/uGuwOR
Benzinga,These Analysts Revise Price Targets On Etsy Following Q1 Results,https://benzinga.com/news/earnings/23/05/32223433/these-analysts-revise-price-targets-on-etsy-following-q1-results,https://da.gd/yln5R6
Benzinga,"Blue Apron Shares Drop Post Q1 Beat, Actively Pursues Option Available To Drive Fundamentals",https://benzinga.com/news/earnings/23/05/32213682/blue-apron-shares-drop-post-q1-beat-actively-pursues-option-available-to-drive-fundamentals,https://da.gd/QppkV
